# Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

> **NCT06223269** · PHASE3 · RECRUITING · sponsor: **XenoTherapeutics, Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Burns Degree Third
- Burn (Disorder)
- Burn Degree Second
- Thermal Burn
- Wound Heal

## Interventions

- **DRUG:** Skin Xenotransplant
- **PROCEDURE:** Autograft(ing)

## Key facts

- **NCT ID:** NCT06223269
- **Lead sponsor:** XenoTherapeutics, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-09
- **Primary completion:** 2025-12
- **Final completion:** 2026-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223269, "Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06223269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*